About Profhilo
Profhilo is an innovative line of injectable bioremodeling treatments developed by IBSA Derma, a division of the Swiss pharmaceutical company IBSA Group. Unlike traditional dermal fillers or skin boosters, Profhilo is formulated with a unique patented technology that stabilizes high- and low-molecular-weight hyaluronic acid without chemical crosslinking. This distinctive dual-action formula delivers deep hydration, stimulates collagen and elastin production, and improves skin architecture from within. Profhilo is widely recognized as a pioneering approach to natural-looking facial and body rejuvenation.
Profhilo H+L
Profhilo represents a new category of injectable treatments—bioremodeling—focusing not only on hydration but also on stimulating tissue regeneration and skin laxity improvement. Its high concentration of pure hyaluronic acid spreads evenly across treatment areas, enhancing skin firmness, elasticity, and overall vitality without altering natural facial expressions. Profhilo treatments are especially effective on the face, neck, décolleté, arms, and hands, making it a versatile solution for comprehensive rejuvenation.
• Profhilo H+L
o Original formulation with a unique hybrid complex of high- and low-molecular-weight hyaluronic acid.
o Provides intense hydration, boosts collagen and elastin synthesis, and improves tissue quality.
o Suitable for patients with early to moderate signs of skin aging and laxity.
Profhilo Structura
o Advanced formulation designed to target deeper structural support and tissue remodeling.
o Improves skin firmness, density, and contour definition while maintaining natural expression.
o Ideal for patients with more pronounced tissue laxity or loss of dermal integrity.
About IBSA Derma
IBSA Derma is the aesthetic medicine division of IBSA Group, a Swiss multinational pharmaceutical company founded in 1945. Known for its expertise in hyaluronic acid technology, IBSA Derma has developed a diverse portfolio of products focused on skin health, beauty, and regeneration. With a strong emphasis on research, clinical safety, and scientific innovation, IBSA Derma is trusted worldwide for pioneering treatments that elevate both patient outcomes and practitioner confidence. Profhilo exemplifies IBSA’s mission to redefine aesthetic medicine through natural, biocompatible, and science-driven solutions.